Strategic Acquisition Pharmasite Research was acquired by Headlands Research in February 2024, signaling potential access to a broader network of clinical trial sites and increased collaboration opportunities for scaled studies in mental health and CNS disorders.

Mental Health Focus Specialization in mental illness and central nervous system disorders suggests opportunities to align with sponsors seeking CNS trial sites and to cross-sell services to Headlands Research network.

Small Team Needs With a lean team size (2-10 employees) and revenue under one million, there may be a need for partner-driven, scalable outsourcing solutions, pharmacovigilance support, and technology platforms that increase efficiency without heavy in-house investment.

Local to Global Potential Based in Pikesville, MD but now part of a multinational network, Pharmasite can be positioned as a gateway for regional trials with access to international sites through Headlands Research partnerships.

Digital Footprint Existing tech stack and online presence (MySQL, analytics, SMTP, CMS tools) indicate receptiveness to vendor-led tech enhancements, data integration, and secure, scalable trial management solutions.